Dow Jones U.S. Pharmaceuticals Index Fund (IHE) Inception date: 5/1/2006
| The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Pharmaceuticals Index. |
| JOHNSON&JOHNSON | 8.93% |
| MERCK&CO. INC. | 7.73% |
| PFIZER INC | 7.67% |
| ABBOTT LABORATORIES | 6.78% |
| ELI LILLY&CO | 5.35% |
| BRISTOL-MYERS SQUIBB CO | 5.15% |
| ALLERGAN INC | 4.55% |
| HOSPIRA INC | 3.87% |
| MYLAN INC | 3.65% |
| FOREST LABORATORIES INC | 3.51% |
| Total | 57.19% |
| *Holdings are subject to change. | |
Sector Breakdown as of 3/19/2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|||||||||
1 Year |
3 Years |
5 Years |
10 Years |
Since Inception | |
|---|---|---|---|---|---|
| IHE | 30.47% | 4.21% | -- | -- | 5.44% |
Index  |
31.06% | 4.75% | -- | -- | 5.98% |
Yield as of 2/26/2010 | ||
|---|---|---|
| 30-Day SEC Yield |
1.30% | |
| Fundamentals & Risk as of 2/26/2010 | ||
|---|---|---|
| Price to Earnings Ratio | 19.06 | |
| Price to Book Ratio | 3.77 | |
| Beta vs S&P 500 | 0.46 | |
| Standard Deviation (3 year) |
18.57% | |
| Profile as of 3/19/2010 | ||
|---|---|---|
| Total Net Assets | $184,380,700 | |
| Expense Ratio | 0.48% | |
| Shares Outstanding | 3,100,000 | |
| Total Holdings | 33 | |
| Inception Date | 5/1/2006 | |
| Related Index | DJSPHMT | |
Net Asset Value as of 3/19/2010 |
$59.48
|
|
Price as of 3/19/2010 |
$59.37
|
|
| The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. This information must be accompanied by standardized returns. For standardized returns and performance data current to the most recent month end, click the "Performance" tab above. | ||
| Fees & Expenses | |||
|---|---|---|---|
| Management Fees | 0.48% | ||
+ |
Acquired Fees & Expenses ‡ | 0.00% | |
= |
Total Annual Fund Operating Expenses | 0.48% | |
| Trading Information | ||
|---|---|---|
| Ticker | IHE | |
| Related Index | DJSPHMT | |
| NAV | IHE.NV | |
| Underlying Trading Value | IHE.IV | |
| Shares Outstanding | IHE.SO | |
| Estimated Cash | IHE.EU | |
| Total Cash | IHE.TC | |
| CUSIP | 464288836 | |
Carefully consider the iShares Funds' investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the Funds' prospectuses, which may be obtained by calling 1-800-iShares (1-800-474-2737) or by viewing or downloading a prospectus. Read the prospectus carefully before investing.
Investing involves risk, including possible loss of principal.
‡ “Acquired Fund Fees and Expenses” reflect the Fund's pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. Acquired Fund Fees and Expenses are reflected in the prices of the acquired funds and thus included in the total returns of the Fund.
The iShares Funds ("Funds") are distributed by SEI Investments Distribution Co. (SEI).
Narrowly focused investments typically exhibit higher volatility.
Pharmaceutical and medical device companies may be subject to severe competition and product obsolescence. These companies may be adversely affected by loss of patent protection, subject to extensive product liability litigation and thinly traded. New products are subject to government approvals, regulation and reimbursement rates.
Index returns are for illustrative purposes only and do not represent actual iShares performance. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.
Dow Jones is a servicemark of Dow Jones & Company and has been licensed for use by BlackRock Institutional Trust Company, N.A. iShares Funds are not sponsored, endorsed, issued, sold or promoted by Dow Jones & Company, nor does this company make any representation regarding the advisability of investing in iShares Funds. Index data source: Dow Jones.
Shares of iShares Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Certain sectors and markets perform exceptionally well based on current market conditions and iShares funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.
©2010 BlackRock Institutional Trust Company, N.A. All rights reserved. iShares® is a registered trademark of BlackRock Institutional Trust Company, N.A. All other trademarks, servicemarks or registered trademarks are the property of their respective owners.
Investing involves risk, including possible loss of principal.
‡ “Acquired Fund Fees and Expenses” reflect the Fund's pro rata share of the indirect fees and expenses incurred by investing in one or more acquired funds, such as mutual funds, business development companies, or other pooled investment vehicles. Acquired Fund Fees and Expenses are reflected in the prices of the acquired funds and thus included in the total returns of the Fund.
The iShares Funds ("Funds") are distributed by SEI Investments Distribution Co. (SEI).
Narrowly focused investments typically exhibit higher volatility.
Pharmaceutical and medical device companies may be subject to severe competition and product obsolescence. These companies may be adversely affected by loss of patent protection, subject to extensive product liability litigation and thinly traded. New products are subject to government approvals, regulation and reimbursement rates.
Index returns are for illustrative purposes only and do not represent actual iShares performance. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.
Dow Jones is a servicemark of Dow Jones & Company and has been licensed for use by BlackRock Institutional Trust Company, N.A. iShares Funds are not sponsored, endorsed, issued, sold or promoted by Dow Jones & Company, nor does this company make any representation regarding the advisability of investing in iShares Funds. Index data source: Dow Jones.
Shares of iShares Funds are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Certain sectors and markets perform exceptionally well based on current market conditions and iShares funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.
©2010 BlackRock Institutional Trust Company, N.A. All rights reserved. iShares® is a registered trademark of BlackRock Institutional Trust Company, N.A. All other trademarks, servicemarks or registered trademarks are the property of their respective owners.
© Copyright 2010
